Correction to: Evaluation of intra-ovarian platelet-rich plasma administration on oocytes-dependent variables in patients with poor ovarian response: a retrospective study according to the POSEIDON criteria

Farimani et al. Reproductive Biology and Endocrinology (2021) 19:169 https://doi.org/10.1186/s12958-021-00849-3 CORRECTION Correction to: Evaluation of intra-ovarian platelet-rich plasma administration on oocytes- dependent variables in patients with poor ovarian response: a retrospective study according to the POSEIDON criteria Marzieh Farimani1, Arash Nazari2, Shahrzad Mohammadi3 and Roghayeh Anvari Aliabad1,4,5* © The Author(s) 2021. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http:// creat iveco mmons. org/ licen ses/ by/4. 0/. The Creative Commons Public Domain Dedication waiver (http:// creat iveco mmons. org/ publi cdoma in/ zero/1. 0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. Correction to: Reprod Biol Endocrinol 19, 137 (2021) https://doi.org/10.1186/s12958-021-00826-w Following publication of the original article [1 ], the authors reported two errors. In the introduction, " A report on 23 women with primary ovarian insufficiency has shown that PRP could be a proper treatment option for these patients." should be changed to " A report on 23 women (of 311) with primary ovarian insufficiency who conceived spontaneously has shown that PRP could be a proper treatment option for these patients." The other one is that the reference number 23 (Sills ES, Rick- ers NS, Li X, Palermo GD. First data on in vitro fertilization and blastocyst formation after intraovarian injection of calcium glu- conate-activated autologous platelet rich plasma. Gynecol Endo- crinol. 2018;34:756–760. doi: 10.1080/09513590.2018.1445219) should be updated as following: Cakiroglu Y, Saltik A, Yuceturk A, Karaosmanoglu O, Kopuk SY, Scott RT, et al. Effects of intraovarian injection of autologous plate- let rich plasma on ovarian reserve and IVF outcome parameters in women with primary ovarian insufficiency. Aging. 2020;12:10211– 22. doi: 10.18632/aging.103403. The original article [1] has been updated. Author details 1 Endometrium and Endometriosis Research Center, Hamadan University of Medical Sciences, Hamadan, Iran. 2 School of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran. 3 School of Medicine, Iran University of Medical Sciences, Tehran, Iran. 4 Department of Gynecology, School of Medi‑ cine, Hamadan University of Medical Sciences, Hamadan, Iran. 5 Endometrium and Endometriosis Research Center, Fatemieh Hospital, Pasdaran Street, P .O. Box, Hamadan 89971‑65177, Iran. Open Access The original article can be found online at https:// doi. org/ 10. 1186/ s12958‑ 021‑ 00826‑w. *Correspondence: [email protected] 5 Endometrium and Endometriosis Research Center, Fatemieh Hospital, Pasdaran Street, P .O. Box, Hamadan 89971‑65177, Iran Full list of author information is available at the end of the article Page 2 of 2Farimani et al. Reproductive Biology and Endocrinology (2021) 19:169 • fast, convenient online submission • thorough peer review by experienced researchers in your field • rapid publication on acceptance • support for research data, including large and complex data types • gold Open Access which fosters wider collaboration and increased citations maximum visibility for your research: over 100M website views per year • At BMC, research is always in progress. Learn more biomedcentral.com/submissions Ready to submit y our researc hReady to submit y our researc h ? Choose BMC and benefit fr om: ? Choose BMC and benefit fr om: Reference 1. Farimani M, Nazari A, Mohammadi S, et al. Evaluation of intra‑ovarian platelet‑rich plasma administration on oocytes‑dependent variables in patients with poor ovarian response: A retrospective study according to the POSEIDON criteria. Reprod Biol Endocrinol. 2021;19:137. https:// doi. org/ 10. 1186/ s12958‑ 021‑ 00826‑w.